Enteralia Bioscience LLC

Holden, MA Part of Nemysis LIMITED

UEI
HYNBSTFHU794
CAGE
9VA57
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Foreign Owned
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
  • Nemysis LIMITED Parent SDZ9RM6691Z7
    • Enteralia Bioscience LLC HYNBSTFHU794
SAM.gov registration date
Physical address
650 S Rd, Holden, MA 01520, USA
Website
enteralia-bioscience.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Enteralia Bioscience LLC's latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
The development of an oral enzymatic therapy adjunctive to the dietary management of celiac disease Grant · HT94252410750 Defense Health Agency $4,239,889

Quick answers

What is Enteralia Bioscience LLC's UEI?

Enteralia Bioscience LLC's Unique Entity ID (UEI) in SAM.gov is HYNBSTFHU794.

What is Enteralia Bioscience LLC's CAGE code?

Enteralia Bioscience LLC's CAGE code is 9VA57.

What is Enteralia Bioscience LLC's primary NAICS code?

Enteralia Bioscience LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Enteralia Bioscience LLC located?

Enteralia Bioscience LLC's physical address in SAM.gov is 650 S Rd, Holden, MA 01520, USA.

Is Enteralia Bioscience LLC registered in SAM.gov?

Yes. Enteralia Bioscience LLC's SAM.gov registration is active through September 30, 2027.

Who is Enteralia Bioscience LLC's parent company?

Enteralia Bioscience LLC is part of Nemysis LIMITED.

What is Enteralia Bioscience LLC's most recent federal award?

Enteralia Bioscience LLC's most recent federal grant award is The development of an oral enzymatic therapy adjunctive to the dietary management of celiac disease (HT94252410750), from Defense Health Agency, on July 1, 2024.

On GovTribe

See Enteralia Bioscience LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login